ArticleMolecular biology reports2026
hnRNP A1 controls MIR17HG alternative splicing and maturation of miR-19a.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlternative splicing is a key process in the regulation of gene expression in eukaryotes. During transcription, the spliceosome machinery assembles onto precursor messenger RNA (pre-mRNA) conserved regions, promoting intron removal and exon ligation. This process is guided and controlled by the association of RNA-binding proteins (RBPs) in the pre-mRNAs. These proteins mediate splice-site choice controlling the splicing profile observed in different cells. The heterogeneous ribonucleoproteins (hnRNPs) A1 and K have previously been associated with intronic regions containing microRNAs (miRNAs). We previously showed hnRNP A1 overexpression increases invasion and cell growth in thyroid carcinoma cells through association with miR-17a and miR-18a. MIR17HG is the host gene for the miR-17-92 miRNA cluster, which is encoded within one of its introns. In this work, we investigated the participation of hnRNP A1 and hnRNP K in MIR17HG alternative splicing. METHODS AND
resultsOverexpression of hnRNP A1 and hnRNP K was performed using pFLAG system in HEK-293FT cells. Reverse transcription quantitative PCR (RT-qPCR) analysis indicated higher levels of MIR17HG-i3 isoforms, which correlated with increase on pre-miR-19a generation upon hnRNP A1 overexpression. Surprisingly, the same pattern was not observed in cells overexpressing hnRNP K. Higher concentration of functional miR-19a in hnRNP A1 overexpressing cells was confirmed by luciferase reporter assays.
conclusionsThese results indicate that hnRNP A1 modulates MIR17HG splicing, with downstream effects on miR-19a biogenesis and maturation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.